Will the Aptera production schedule be adversely affected by the current global constraints on chips?

Apparently chip production is being ramped up quickly, so it probably won't still be an issue by the time Aptera starts needing more.

You can bet it's something they are having to deal with. That they are still only using prototype quantities may be a distinguishing point. I'd guess only time will tell regarding adverse effects.